Sertraline Tablets

Contract SPE2D2-26-D-0012 is a follow-on award issued by the Defense Logistics Agency (DLA) Troop Support to Exelan Pharmaceuticals, Inc. for the supply of Sertraline tablets in 25MG, 50MG, and 100MG dosages. The contract has a total estimated value of $22,510,720.70 over a five-year period, consisting of a base year and four option years. Performance and manufacture take place at the InvaGen Pharmaceuticals facility in Hauppauge, New York, with deliveries made FOB Destination. The supplies are provided in various bottle counts, ranging from 30 to 500, and are identified by specific National Drug Codes. The agreement is governed by FAR Part 12 for commercial items and includes a wide array of federal compliance mandates. Key requirements include strict cybersecurity protocols under NIST SP 800-171, supply chain restrictions prohibiting equipment from certain foreign entities, and adherence to pharmaceutical-specific DFARS clauses regarding sourcing and transportation. Administrative requirements mandate electronic submission of payment requests and compliance with various labor and employment standards, including E-Verify and the Service Contract Labor Standards. The contract was signed and awarded on April 21, 2026.